• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Companies Company News

NIVEA manufacturer reacts to NAFDAC’s alert, says recalled product not sold in Nigeria 

Anthonia Obokoh by Anthonia Obokoh
November 2, 2024
in Company News, Health, Sectors
NAFDAC recalls Nivea roll-on deodorant over harmful chemical content 
Share on FacebookShare on TwitterShare on Linkedin

Beiersdorf, the parent company of NIVEA, has clarified that its NIVEA Black & White Invisible Roll-On Deodorant with batch number 93529610, is not available for sale in Nigeria.

Beiersdorf stated this in a statement on Saturday, responding to a safety alert issued by the National Agency for Food and Drug Administration and Control (NAFDAC) on the product.

On October 31, the NAFDAC alerted Nigerians to the recall of the product by the European Union’s (EU) rapid alert system for dangerous non-food products (RAPEX) in Brussels.

MoreStories

Federal Competition and Consumer Protection Commission (FCCPC) Logo

FCCPC to sanction five airlines guilty of festive season price fixing

March 12, 2026
Technical and Vocational Education and Training (TVET)

FG unveils PICOMS portal to curb procurement delays in education projects

March 12, 2026

The agency had earlier stated that Nivea products contain 2-(4-tert-Butylbenzyl propionaldehyde (BMHCA), stating that a chemical prohibited in cosmetics products due to its ability to cause harm to the reproductive system, impairs the health of an unborn child as well as skin irritation and burns to users.

NAFDAC said the chemical, BMHCA, is prohibited in cosmetic products because it could trigger skin irritation and also affect the reproductive health of its users or an unborn child.

The agency said the product, produced in Germany, is marked ‘48H protection in African climate’, with batch number: 93529610 and bar code number: 42299882.

Product information and compliance 

The company disclosed that based on current European legislation, the use of ingredient 2-(4-tert-Butylbenzyl propionaldehyde (LilialTM) in cosmetic products has been banned from the European markets as of March 1, 2022.

“We wish to assure our esteemed customers that the Batch No. 93529610 in question has not been marketed in Nigeria and thus never recalled by Beiersdorf, the owner of NIVEA brand, as the legal manufacturer.  

“The batch in question, in fact, expired in January 2022 and was hence at the time fully compliant with the then valid European cosmetic regulation,” Beiersdorf’s statement reads.  

 Commitment to consumer safety 

Beiersdorf emphasized its commitment to consumer safety, stating,” As a responsible corporate citizen, Beiersdorf is working collaboratively with NAFDAC to safeguard the interest of the Nigerian consumers by ensuring that our locally manufactured product meets the global quality standards. 

 “The safety of our consumers remains our highest priority, consistent with our ethical philosophy as a business.” 

 Proactive reformulation efforts 

  •  To align with the EU regulation, Beiersdorf confirmed that it reformulated its entire NIVEA product portfolio to be Lilial-free ahead of the March 2022 ban.
  • For instance, the NIVEA Black & White Invisible Roll-On Deodorant has been free of Lilial since at least 2020, globally, including in Nigeria.
  • Beiersdorf said it notified its trade partners early on, urging them to remove any outdated Lilial-containing products within the legal timeframe as required by the European Cosmetic Product Regulation.

Add Nairametrics on Google News
Follow us for Breaking News and Market Intelligence.
Tags: BeiersdorfNAFDACNIVEANivea BLACK &WHITE Invisible Roll-on deodorant
Anthonia Obokoh

Anthonia Obokoh

Anthonia Obokoh is journalist with years experience in the media industry, focusing on health reporting. Known for her expertise as a health writer and analyst, she brings depth to topics from public health policies to healthcare advancements. Her work has earned her recognition as a trusted voice in Nigeria’s health journalism field.

Next Post
X may lose $75m in revenue as advertisers walkout

Elon Musk faces legal setback in Court battle over Twitter severance payouts 

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

rabafast
rabafast

nairametrics





DUNS

Follow us on social media:

  • HOME
  • ABOUT NAIRAMETRICS
  • CONTACT US
  • DISCLAIMER
  • ADs DISCLAIMER
  • COPYRIGHT INFRINGEMENT

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics